Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04424966
Title Infigratinib in Recurrent Glioblastoma Patients
Recruitment Recruiting
Gender both
Phase Phase 0
Variant Requirements Yes
Sponsors Nader Sanai
Indications

high grade glioma

Therapies

Infigratinib

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST